Since today's society is characterised by an increase in the number of elderly persons, who are subject more than any other group to an alteration in their state of nutrition, in this review we propose the possible methods that can be used for an accurate nutritional diagnosis in this age group. Considering that malnutrition, sarcopenia and motor disability are factors that are more likely to occur with aging, it is extremely important for certain clinical anamnestic parameters, such as biohumoral and anthropometric indicators, but also specific tables and questionnaires, to become standard routine practice in health care in order to facilitate the diagnosis of these possible events.
View Article and Find Full Text PDFA huge interest in the scientific community has been aroused since leptin's discovery (from greek leptos=thin), due to its important role in the body energetic balance regulation. This protein is synthesized from ob gene and secreted by the adipose tissue when fat mass increases, decreasing hunger and increasing energy expenditure in order to restore energetic balance. In the latest years many human genetic studies have been conducted showing that sometimes obesity may be due to mutations of genes involved in energetic balance mediated by leptin.
View Article and Find Full Text PDFBackground: Obesity is well known to be a problem all over the world: WHO data report that one billion subjects are overweight and 300 million are obese. Epidemiological data (IOTF) show that prevalence rates are increasing not only in industrialized countries, but also in developing countries, especially as far as the adolescent population is concerned.
Aim Of The Study: To select adolescents at risk of obesity by BMI calculation and by other anthropometric and functional measurements in the Aosta Valley Mountain Region (Northern Italy).
The luteinizing hormone (LH) response to metoclopramide (MCP), a dopamine receptor antagonist, and naloxone (NAL), an opioid receptor antagonist, was evaluated in 7 patients with polycystic ovarian disease (PCOD) before and during treatment with purified human urinary follicle-stimulating hormone (hFSH), and in 6 control women during spontaneously ovulating cycles. Before treatment, in all patients both MCP and NAL administration did not increase plasma LH levels. In the 6 subjects ovulating following hFSH treatment the LH response to MCP and NAL at preovulatory and midluteal phases was restored, as it occurred in control women.
View Article and Find Full Text PDF